Call: (+232) 72-641729
Email: info@igr-sl.org
Significant Progress
87:86:65
" "
While 87:86:65 reflects substantial progress in testing and treatment coverage, gaps towards the 2030 target of 98:98:98 and ultimately achieving sustained epidemic control; include strengthening adherence support, improving retention in care, and expanding access to viral load testing.